Advanced B-cell Lymphoid Malignancies Recruiting Phase 0 Trials for Roflumilast (DB01656)

IndicationStatusPhase
DBCOND0063933 (Advanced B-cell Lymphoid Malignancies)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01888952Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)Treatment